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SHORT SUMMARY 
A U.S. national sample of gay and bisexual men completed at-home self-administered testing for 
urethral and rectal gonorrhea/chlamydia (GC/CT). In total 6.2% were GC/CT positive (5.3% 
rectal, 1.7% urethral). 
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ABSTRACT 
Background. Gay and bisexual men (GBM) are at elevated risk for gonorrhea and chlamydia 
trachomatis (GC/CT). Rectal GC/CT symptoms may be less obvious than urethral, increasing 
opportunities for undiagnosed rectal GC/CT.  
Method. A U.S. national sample of 1,071 GBM completed urethral and rectal GC/CT testing and 
an online survey. 
Results. In total, 6.2% were GC/CT positive (5.3% rectal, 1.7% urethral). We calculated 
adjusted (for education, race, age, relationship status, having health insurance, and income) odds 
ratios for factors associated with rectal and urethral GC/CT diagnoses. Age was inversely 
associated with urethral and rectal GC/CT. Compared to White men, Latinos had significantly 
greater odds of rectal GC/CT. Among men who reported anal sex, those reporting only insertive 
sex had lower odds of rectal GC/CT than men who reported both insertive and receptive. There 
was a positive association between rectal GC/CT and number of male partners (<12 months), the 
number of anal receptive acts, receptive condomless anal sex (CAS) acts, and insertive CAS acts.  
Compared to those who had engaged in both insertive and receptive anal sex, those who 
engaged in only receptive anal sex had lower odds of urethral GC/CT. The number of male 
partners (<12 months) was associated with increased odds of urethral GC/CT.  
Conclusion. Rectal GC/CT was more common than urethral and associated with some 
demographic and behavioral characteristics. Our finding that insertive CAS acts was associated 
with rectal GC/CT highlights that providers should screen patients for GC/CT via a full range of 
transmission routes, lest GC/CT go undiagnosed.   
 
 
KEYWORDS: men who have sex with men; gonorrhea; chlamydia 
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Introduction 
Gay, bisexual, and other men who have sex with men (GBMSM) represent 4-15% of the 
U.S. population(1, 2) and are disproportionally affected by sexually transmitted infections, 
including Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT)(3, 4). In 2013, in the 
U.S. STD surveillance network—comprised of 42 STD clinics within 12 collaborating 
jurisdictions—GC prevalence was 16.9% (range by site: 10.4%–28.1%) and CT prevalence was 
15.2% (range by site: 7.4%–30.7%) among GBMSM(4). Across collaborating jurisdictions, 
27.4% of GC cases were estimated to be among GBMSM, 30.5% among men who have sex with 
women, and 42.1% among women—comparable data on CT were not reported.  
Testing for GC and CT has historically been conducted with culture, however, Nucleic 
Acid Amplification Tests (NAAT) (e.g., the Abbott Real-Time, Aptima COMBO 2 assay, 
cobas® 4800) are now recommended by the U.S. Food and Drug Administration as the standard 
diagnostic tests for their increased sensitivity, specificity, and ease of specimen transport(5). The 
most common methods by which GC and CT are tested are through the collection of urine. 
Urine-based screening allows for self-collection(6) with minimal sample collection barriers 
compared to urethral specimens that need to be collected in a clinic setting(7). Patients provide a 
first-catch urine specimen that is transferred to a test specific transport tube. Fewer studies have 
examined the prevalence of rectal GC and CT, which is typically identified via a swab of the 
rectum and culture. NAATs are not FDA approved for rectal specimens, limiting their 
accessibility at private practice settings compared to public health STD clinics(8). Patients self-
swab the inside of the rectum and break off the swab into a test specific transport tube. Self-
sampling has been compared to clinic-based testing finding high viability and acceptability with 
a variety of populations including MSM(6, 9). Although GBMSM do not engage in anal sex 
3 
every time they have sex(10), there remains a need to test for urethral as well as rectal GC/CT 
given that many GBMSM do engage in insertive as well as receptive anal sex(11, 12). Studies of 
GBMSM who engage in anal sex have found that rates of engaging in receptive as well as 
insertive anal sex (i.e., versatility) ranged from moderate (e.g., 38%(13))  to high (e.g., 73%(14), 
83%(15)), suggesting that a significant portion of GBMSM should be routinely screened for 
urethral as well as rectal STIs.   
As a result of the continuing HIV and STI epidemics, much of researchers’ attention to 
GBMSM has been grounded in HIV prevention. And, much of what we know about GBMSM 
has been based on samples in urban epicenters. As a result, less is known about U.S. GBMSM 
who live outside of urban centers. Although CDC surveillance data is helpful with identifying 
incident HIV and STIs, much of these data are limited to urban centers and/or collected at STD 
clinics (i.e., self-selected samples of individuals who perceive themselves to need, or are referred 
for, STI testing). Furthermore, surveillance data is restricted in that it provides little context as to 
social and behavioral factors that are associated with STI diagnoses.  
With the expanded use of the Internet both by researchers as well as GBMSM, engaging 
geographically diverse samples of GBMSM in research has become and increasingly acceptable 
method of data collection(16-20). Recently, researchers have begun combining online data 
collection with self-administered biological data collection, particularly for HIV among 
GBMSM(21, 22). Less is known about the use of at-home self-administered testing for STIs 
among GBMSM; however studies suggest it is feasible and acceptable(9, 23). To that end, the 
present study reports on rates of urethral and rectal GC/CT diagnosis in a U.S. national sample of 
HIV-negative GBM, as well as factors associated with urethral and rectal diagnosis.  
Method 
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Participants and Procedures         
The One Thousand Strong panel is a longitudinal study following a U.S. national sample 
of gay and bisexual men (GBM) for a period of three years [BLINDED FOR REVIEW](24). 
Analyses for the present manuscript were based on baseline data. Participants were identified via 
Community Marketing and Initiatives (CMI) panel of over 45,000 LGBT individuals, over 
22,000 of whom are GBM throughout the United States. CMI draws panelists from over 200 
sources ranging from LGBT events to social media and non-gay identified venues/mediums 
(e.g., social media). Participants in the One Thousand Strong panel were targeted to represent the 
diversity and distribution of GBM in the U.S. population. In so doing, recruitment targets were 
established using data from the U.S. Census with regard to same sex households and racial and 
ethnic composition.  
CMI emailed potential participants with a brief description of the study along with a link 
to a brief 2-minute survey that would determine preliminary eligibility criteria (e.g., reside in the 
U.S., be at least 18 years of age, be biologically male and currently identify as male, identify as 
gay or bisexual, report having sex with a man in the past year, self-identify as HIV-negative, 
willing to complete at-home self-administered rapid HIV antibody testing, willing to complete 
self-administered testing for urine and rectal GC/CT, able to complete assessments in English, 
have access to the Internet such to complete at-home online assessments, have access to a device 
that was capable of taking a digital photo (e.g., camera phone, digital camera), have an address to 
receive mail that was not a P.O. Box, and were residentially stable (i.e., have not moved more 
than twice in the past 6 months)). Those meeting these preliminary criteria were invited to join 
the study and presented with informed consent. Those consenting had their contact information 
shared with the research team to follow up for enrollment in the study. The research team 
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emailed participants a link to a secure online survey that took approximately one-hour to 
complete. Participants were mailed a kit for self-collection of urine and rectal GC/CT specimens 
as well as at-home OraQuick
©
 HIV testing. Urine and rectal samples were returned mail to the 
lab at Emory University for analysis. Participants were compensated $25 for completing the first 
hour-long at-home survey and an additional $25 for HIV/STI testing procedures.  
 Participants were enrolled between April 2014-October 2014. The [BLINDED] 
Institutional Review Board approved study procedures.  
Measures 
 STI testing. GC/CT were tested using the Abbott m2000 Real-Time assay. Specimens are 
collected using the Abbott multi-Collect Specimen Collection Kit and can be stored for up to 14 
days. This NAAT assay uses a polymerase chain reaction (PCR) testing approach where DNA is 
extracted. If CT and GC are present, their sequences are amplified and detected with fluorescent-
labeled oligonucleotide probes(25). During the enrollment process, there were 26 participants not 
enrolled in the panel because they failed to complete the STI testing procedures and an additional 
7 men whose samples resulted in inconclusive results. Attempts to resample these men were 
unsuccessful.  Meanwhile, among the 1071 enrolled in the panel, only 2.8% (n = 30) experienced 
an STI sampling error (e.g., fecal contamination of the rectal swab, urine vial improperly sealed 
and came open during transit to the lab, rectal swab inserted into the vial containing urine) and < 
1% (n = 8) had to be resent a kit because it was reported as lost in the mail—either not received 
by participant or not received by lab after reportedly being mailed. Our attempts to resample 
these 30 participants were successful.  
Demographic and behavioral characteristics. Participants reported demographic 
characteristics including race/ethnicity, education, income, age, sexual identity, whether they had 
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used illegal drugs (cocaine, methamphetamine, ecstasy/MDMA, GHB/GBL, heroin/opiates, 
ketamine, crack) in the prior 3 months, and whether they had health insurance and a primary 
doctor. Participants also reported their sexual behavior including the number of times they 
engaged in receptive and/or insertive condomless anal sex (CAS) with an HIV-positive or 
unknown status main partner or any casual male partners in the prior 3 months.  
Analytic Plan 
 We first describe the prevalence of rectal and urine GC/CT as well as demographic and 
behavioral characteristics of the sample. As appropriate, we next report unadjusted and adjusted 
odds ratios for the association between demographic and behavioral characteristics with testing 
positive for rectal or urethral CG/CT. Adjusted odds ratios accounted for the effects of education, 
race, age, relationship status, having health insurance, and income.  Finally, using Mann-
Whitney U tests, which account for the non-normal distribution of count variables, we reported 
bivariate associations between various sexual behaviors (e.g., number of anal insertive acts, 
number of receptive anal sex acts) and diagnosis with rectal or urethral GC/CT.  
Results 
Figure 1 indicates the distribution of participants across the US. Participants represented 
49 of 50 states. Table 1 presents descriptive characteristics of the One Thousand Strong panel. In 
total, 95% were self-identified as gay, 29% were men of color, and the average age was average 
age of 40.2. Nearly half (48.7%) were in a relationship, 91.8% reported having health insurance, 
76.0% reported having a primary care provider, and 10.8% reported drug use in the prior 3 
months. With regard to sexual behavior, 39.2% reported having engaged in CAS with a casual 
male partner or with an HIV-positive or HIV-unknown main partner in the prior 3 months. 
Nearly half (49.8%) said they had not engaged in any anal sex in the past 3 months, 12.3% 
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reported only acts of anal receptive sex, 20% reported both insertive and receptive anal sex 
(versatile), and 17.6% reported only anal insertive sex.  
In total, 6.2% tested positive for rectal or urethral GC/CT. Rectal STIs were more 
common than urethral (5.3% vs. 1.7%), and CT was more common than GC (5.3% vs. 1.8%). 
Nine men (0.8%) were diagnosed with both rectal and urethral STIs, 9 men (0.8%) with just a 
urethral STI, and 48 men (4.6%) with just a rectal STI.  
-Figure 1- 
-Table 1- 
 Table 2 reports unadjusted and adjusted odds ratios for factors associated with rectal 
GC/CT diagnosis. Several bivariate associations were no longer significant after adjusting for the 
effects of other variables. These included income, relationship status, and drug use in the prior 3 
months. Compared to White men, Latino men had significantly greater odds of having a rectal 
STI. Among men who reported anal sex, those reporting only insertive anal sex had significantly 
lower odds of being diagnosed with a rectal STI than men who reported both insertive and 
receptive sex. Recent CAS was associated with rectal STIs. There was a negative association 
between age and rectal GC/CT. There was a positive association between rectal GC/CT and the 
number of male partners in the past 12 months, the number of anal receptive acts, receptive CAS 
acts, and insertive CAS acts.  
-Table 2- 
 Table 3 reports unadjusted and adjusted odds ratios for factors associated with urethral 
GC/CT diagnosis. Age was inversely associated with urethral GC/CT diagnosis. No other 
demographic characteristics were associated with urethral GC/CT diagnosis. However some 
behavioral characteristics were. Adjusting for the effects of education, race, age, relationship 
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status, having health insurance, and income, compared to those who said they had engaged in 
both insertive and receptive anal sex, those who said they engaged in only receptive anal sex had 
significantly lower odds of testing positive for urethral GC/CT. In addition, the number of male 
partners in the past 12 months was associated with increased odds of urethral GC/CT diagnosis. 
Interestingly, the number of insertive and receptive anal sex acts with and without a condom 
were all positively associated with testing positive for urethral GC/CT (at the bivariate level); 
however, these effects did not hold up after accounting for the effects of education, race, age, 
relationship status, having health insurance, or income.  
--Table 3-- 
Discussion 
 Participants completed at-home self-administered STI sample collection and mailed those 
to a lab for analyses with minimal errors, suggesting high feasibility and acceptability for 
incorporating at-home self-administered STI sample collection into studies that would otherwise 
be entirely online. In this study 6.2% tested positive for rectal or urethral GC/CT with rectal STIs 
being more common than urethral (5.3% vs. 1.7%), and CT was more common than GC (5.3% 
vs. 1.8%). Our rates of new diagnoses were lower than CDC surveillance; however, it is worth 
noting the intrinsic differences between surveillance data and our sample. Surveillance data are 
collected via STD clinics, and those attending clinics are likely doing so because they are 
experiencing symptoms of an infection. Our sample also excluded HIV-positive men, who are 
included in surveillance data.  
We believe the discrepancy between urethral and rectal GC/CT might be a combined 
result of multiple variables operating at different levels of the sexual health care continuum(26-
29). These include an individual’s own failure to recognize the symptoms of rectal STI infection 
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(which can include discharge or be asymptomatic)(30) relative to the more pronounced 
symptoms of urethral infection, and thus a patients’ failure to seek out testing/treatment. Second, 
there may be lower acceptability—by providers and by patients—of the method by which 
samples for rectal STI are collected (e.g., a medical provider inserting a swab into the rectum vs. 
self-collection through routine urination). Third, both patients and providers may have 
discomfort around discussing sexual behavior and sexual health, particularly anal sexual health. 
Fourth, a failure on behalf of medical providers to suggest/provide rectal STI testing to their 
GBM patients as a part of his routine medical care as well as a failure on behalf of patients to 
request it. Fifth, there may be insurance coverage gaps whereby routine testing for urethral STIs 
is covered but rectal STIs is not. Our study did not assess frequency of STI testing nor methods 
of STI testing (e.g., urethral and rectal) thus cannot comment as to the extent that higher rates of 
rectal STIs are a factor of one of the aforementioned hypotheses. In addition, we did not collect 
data on perceived STI symptoms (e.g., pain, discharge), which would have been useful for the 
present study. 
 In our study, STI diagnoses appeared to be more so a factor of behavioral as opposed to 
demographic characteristics. That is, and perhaps unsurprising, men who reported a history of 
CAS were more likely to also be diagnosed with GC/CT, and there was a positive association 
between number of male partners in the prior 12 months and GC/CT diagnoses. Although it may 
seem counterintuitive that, for example, receptive CAS acts were associated with urethral 
CT/GC, we highlight that receptive CAS was positively correlated with insertive CAS. 
Limitations 
 Although we used parameters taken from the Census to establish recruitment targets (e.g., 
geographic distribution of same-sex male couples, age, race and ethnicity), this was based on 
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data on same-sex households (i.e., couples). The Census does not collect data on sexual identity 
or sexual behavior, thus the true prevalence/distribution of GBM across the U.S. remains 
unknown. It is possible to weight our data to correct for deviation in our sample (with regard to 
characteristics such as race and ethnicity, geographic diversity, and age), but this requires for the 
population characteristics to be known. Certainly other datasets could also be used for post hoc 
sample weights (e.g., CDC surveillance data); however, we also highlight that adding sample 
weights to match our dataset to CDC surveillance data simply corrects for our sample to match 
another sample, not to a population.  
 We used the Abbott m2000 Real-Time assay for detecting STI infection. This test is shelf 
stable using the multi-Collect Specimen Collection kit and samples can be stored at room 
temperature for up 14 days. The method of detection was a NAAT PCR, which has a sensitivity 
of 95.2% for CT/ 98.7% for GC and a specificity of 99.3% for CT/ 99.2% for GC, thus the 
chances of a false positive and false negative are low(5). We recognize that other methods of STI 
detection exist, including the BD ProbeTec ET CT/GC Amplified DNA Assay (Becton 
Dickinson and Company, Sparks, MD); however, this too is not without limitations (e.g., 
decreased specificity due to cross-reactivity with genes from related GC species). Further, we 
tested only for GC/CT, but not other STIs such as genital warts, genital herpes, or syphilis. These 
STIs are detected via blood draw, which would not have been feasible for the present study. 
Further, we did not assess for pharyngeal infections.  
 By partnering with CMI to enroll members from their LGBT panel, we were able to 
engage a population that is already attuned to participating in web-based studies. This ensures 
participants are familiar with, for example, how to complete a survey online as well as how to 
use a computer. Individuals who do not know how to use a computer or do not have Internet 
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access would not be eligible to be a CMI panelist and thus would not be represented in this 
present study. This bias toward a more technologically savvy population should be noted.  
Conclusions 
The One Thousand Strong panel is prospectively following 1,071 HIV-negative GBM 
from across the United States. In addition to online components, we were able to engage the 
panel in self-administered at-home STI testing and only a small proportion of potential 
participants failed to complete these procedures. This suggests that there is high feasibility and 
acceptability in incorporating self-administered STI testing into research studies that would be 
otherwise fully online. Rectal GC/CT was more common than urethral and associated with some 
demographic and behavioral characteristics. Our finding that insertive CAS acts was associated 
with rectal GC/CT highlights the importance for providers to screen patients for GC/CT via a full 
range of transmission routes, lest GC/CT go undiagnosed.   
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Table 1. Demographic characteristics, N = 1071     
      n % 
Rectal or urethral GC and/or CT (i.e., any STI diagnosis) 66 6.2 
  Rectal CG and/or CT 57 5.3 
    Rectal GC 19 1.8 
    Rectal CT 47 4.4 
  Urethral GC and/or CT 18 1.7 
    Urethral GC 5 0.5 
    Urethral CT 15 1.4 
Income     
  < $50,000 575 53.7 
  $50,000 + 496 46.3 
Sexual identity     
  Gay 1017 95.0 
  Bisexual 54 5.0 
Has a 4-year college degree     
  No 474 44.3 
  Yes 597 55.7 
Relationship status     
  Single 549 51.3 
  In a relationship 522 48.7 
Race and Ethnicity     
  Black 83 7.7 
  Latino 135 12.6 
  White 763 71.2 
  Multiracial or "other" 90 8.4 
Has health insurance     
  Yes 983 91.8 
  No 88 8.2 
Has a primary care provider 814 76.0 
Any drug use,
1
 < 3 months 107 10.8 
Anal sexual behavior with casual male partners, < 3 months     
  No anal sex 533 49.8 
  Exclusive bottom 132 12.3 
  Versatile 217 20.3 
  Exclusive top 189 17.6 
CAS
2
 with a casual male partner or HIV-positive or HIV-unknown main partner, < 3 
months 420 39.2 
CT Chlamydia trachomatis, GC Neisseria gonorrhoeae     
1
 Cocaine, methamphetamine, ecstasy/MDMA, GHB/GBL, heroin/opiates, 
ketamine, crack     
2 
Condomless anal sex 
 
 
 
 
     
2 
Table 2. Demographic and behavioral characteristics associated with rectal GC/CT diagnosis
n % n % 95% CI 95% CI
Income
< $50,000 536 52.9 39 68.4 0.52 0.29 - 0.92 0.79 0.41 - 1.50
$50,000 + 478 47.1 18 31.6
Has a 4-year college degree
No 444 43.8 30 52.6 0.70 0.41 - 1.20 0.87 0.49 - 1.53
Yes 570 56.2 27 47.4
Relationship status
Single 512 50.5 37 64.9 0.55 0.32 - 0.96 0.62 0.35 - 1.09
In a relationship 502 49.5 20 35.1
Race and ethnicity
White (Ref.) 729 71.9 34 59.6 Ref. -- - -- Ref. -- - --
Black 79 7.8 4 7.0 1.09 0.38 - 3.14 0.96 0.56 - 1.64
Latino 121 11.9 14 24.6 2.48 1.29 - 4.76 2.01 1.02 - 3.97
Multiracial or "other" 85 8.4 5 8.8 1.26 0.48 - 3.31 1.00 0.37 - 2.70
Has health insurance
No 85 8.4 8 14.0 0.56 0.26 - 1.22 0.73 0.33 - 1.64
Yes 929 91.6 49 86.0
Has a primary care providers
Yes 774 76.3 40 70.2 1.37 0.76 - 2.46 0.90 0.47 - 1.72
No 240 23.7 17 29.8
Any drug use,
1
 < 3 months
No 841 89.8 42 79.2 2.29 1.14 - 4.61 1.89 0.93 - 3.85
Yes 96 10.2 11 20.8
Exclusive bottom 122 24.7 10 22.7 0.49 0.23 - 1.04 0.48 0.22 - 1.03
Versatile (Ref.) 186 37.7 31 70.5 Ref. -- - -- Ref. -- - --
Exclusive top 186 37.7 3 6.8 0.10 0.03 - 0.32 0.11 0.03 - 0.36
No 633 62.4 18 31.6 3.60 2.03 - 6.38 3.26 1.82 - 5.83
Yes 381 37.6 39 68.4
M SD M SD t p
Age in years 40.6 13.8 34.4 13.8 3.29 < .001 0.97 0.95 - 0.99
Mdn IQR Mdn IQR U p
Male partners in the last 12 months 4 1-10 8.0 5-15 39448.0 < .001 1.02 1.01 - 1.03
Sexual behavior with casual male partners in the last 3 months, valid n  = 1071
Number of anal insertive acts 0 0-2 2 0-7.5 36719.0 < .001 1.01 0.993 - 1.04
Number of anal receptive acts 0 0-1 2 0-7 42140.0 < .001 1.03 1.01 - 1.06
Number of condomless anal insertive acts 0 0-0 1 0-3 36891.0 < .001 1.06 1.02 - 1.10
Number of condomless anal receptive acts 0 0-0 1 0-3 40033.0 < .001 1.04 1.01 - 1.08
M  Mean, SD  Standard Deviation, Mdn  Median, IQR Interquartile Range, U  Mann-Whitney U
CT Chlamydia trachomatis , GC Neisseria gonorrhoeae
a
Adjusted for education, race, age, relationship status, having health insurance, and income
Bold items are significant at p < .05
1
 Cocaine, methamphetamine, ecstasy/MDMA, GHB/GBL, heroin/opiates, ketamine, crack
2 
Condomless anal sex
Anal sexual behavior with casual male partners,    
< 3 months, excluding men who did not report anal 
sex with a casual male partner, valid n  = 538
Adj. 
Odds 
Ratio 
a
Rectal GC and/or CT
No Yes
Odds 
Ratio
Adj. 
Odds 
Ratio 
a
CAS
2
 with a casual male partner or HIV-positive 
or HIV-unknown main partner, < 3 months
3 
Table 3. Demographic and behavioral characteristics associated with urethral GC/CT diagnosis
n % n % 95% CI 95% CI
Income
< $50,000 562 53.4 13 72.2 0.44 0.16 - 1.24 0.98 0.30 - 3.20
$50,000 + 491 46.6 5 27.8
Has a 4-year college degree
No 462 43.9 12 66.7 0.39 0.15 - 1.05 0.47 0.17 - 1.34
Yes 591 56.1 6 33.3
Relationship status
Single 540 51.3 9 50 1.05 0.42 - 2.67 1.26 0.49 - 3.27
In a relationship 513 48.7 9 50
Race and ethnicity
White (Ref.) 750 71.2 13 72.2 Ref. -- - -- Ref. -- - --
Black 81 7.7 2 11.1 1.42 0.32 - 6.41 1.09 0.51 - 2.35
Latino 133 12.6 2 11.1 0.87 0.19 - 3.89 0.49 0.11 - 2.25
Multiracial or "other" 89 8.5 1 5.6 0.65 0.08 - 5.01 0.48 0.06 - 3.77
Has health insurance
No 90 8.5 3 16.7 0.47 0.13 - 1.65 0.62 0.17 - 2.27
Yes 936 91.5 15 83.3
Has a primary care providers
Yes 803 76.3 11 61.1 2.04 0.78 - 5.33 1.24 0.43 - 3.57
No 250 23.7 7 38.9
Any drug use,
1
 < 3 months
No 869 89.3 14 82.4 1.79 0.51 - 6.33 1.37 0.37 - 4.95
Yes 104 10.7 3 17.6
Exclusive bottom 131 25 1 7.1 0.16 0.02 - 1.25 0.12 0.01 - 0.95
Versatile (Ref.) 207 39.5 10 71.4 Ref. -- - -- Ref. -- - --
Exclusive top 186 35.5 3 21.4 0.33 0.09 - 1.23 0.36 0.09 - 1.38
No 647 61.4 4 22.2 5.58 1.82 - 17.06 5.55 1.78 - 17.29
Yes 406 38.6 14 77.8
M SD M SD t p
Age in years 40.4 13.8 31.0 10.7 2.87 0.004 0.94 0.90 - 0.99
Mdn IQR Mdn IQR U p
Male partners in the last 12 months 4.0 1-10 10.5 4-20 13121.0 0.01 1.03 1.01 - 1.05
Sexual behavior with casual male partners in the last 3 months, valid n  = 1071
Number of anal insertive acts 0 0-2 4.0 0-7.5 13220.0 0.001 1.02 0.99 - 1.06
Number of anal receptive acts 0 0-1 1.0 0-7.75 12637.0 0.004 1.03 1.00 - 1.06
Number of condomless anal insertive acts 0 0-0 1.0 0-4.25 13894.0 < .001 1.07 1.00 - 1.14
Number of condomless anal receptive acts 0 0-0 0.0 0-4.5 11625.0 0.02 1.03 0.99 - 1.06
M  Mean, SD  Standard Deviation, Mdn  Median, IQR Interquartile Range, U  Mann-Whitney U
CT Chlamydia trachomatis , GC Neisseria gonorrhoeae
a
Adjusted for education, race, age, relationship status, having health insurance, and income
Bold items are significant at p < .05
1
 Cocaine, methamphetamine, ecstasy/MDMA, GHB/GBL, heroin/opiates, ketamine, crack
2 
Condomless anal sex
Anal sexual behavior with casual male partners,   
< 3 months, excluding men who did not report anal 
sex with a casual male partner, valid n  = 538
Adj. 
Odds 
Ratio 
a
Urethral GC and/or CT Adj. 
Odds 
Ratio 
a
No Yes
Odds 
Ratio
CAS
2
 with a casual male partner or HIV-positive 
or HIV-unknown main partner, < 3 months
3 
 
 
 
Figure 1. Distribution of One Thousand Strong participants across the United States 
 
 
 
